Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing Remitting Multiple Sclerosis (RRMS)”

180 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 180 results

Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Testing effectiveness (Phase 2)Ended earlyNCT02222948
What this trial is testing

Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Genzyme, a Sanofi Company 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT06800404
What this trial is testing

"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Multiple Sclerosis
Hope Biosciences Research Foundation 10
Not applicableStudy completedNCT00818038
What this trial is testing

A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 30
Early research (Phase 1)Active Not RecruitingNCT06430671
What this trial is testing

Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Cellerys AG 11
Large-scale testing (Phase 3)UnknownNCT01464905
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Nuron Biotech Inc. 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07006805
What this trial is testing

RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis (RMS)Progressive Multiple Sclerosis (PMS)Multiple Sclerosis - Relapsing Remitting+4 more
Cabaletta Bio 12
Large-scale testing (Phase 3)Ended earlyNCT01499667
What this trial is testing

Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Novartis Pharmaceuticals 142
Large-scale testing (Phase 3)UnknownNCT01333358
What this trial is testing

Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Central Texas Neurology Consultants 30
Not applicableStudy completedNCT00884481
What this trial is testing

Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMS

Who this might be right for
Relapsing-Remitting Multiple SclerosisFatigue
Biogen 195
Large-scale testing (Phase 3)Study completedNCT02283853
What this trial is testing

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 156
Not applicableStudy completedNCT01695434
What this trial is testing

A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months

Who this might be right for
Multiple Sclerosis
University at Buffalo 60
Not applicableUnknownNCT04030819
What this trial is testing

Effectiveness of a Schema Therapy on Anxiety in Patients With Multiple Sclerosis

Who this might be right for
Anxiety
Paris Nanterre University 106
Not applicableStudy completedNCT01080053
What this trial is testing

Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing Remitting
Merck KGaA, Darmstadt, Germany 306
Post-approval studies (Phase 4)Ended earlyNCT03126760
What this trial is testing

Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Mallinckrodt ARD LLC 35
Not applicableStudy completedNCT01592097
What this trial is testing

Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS

Who this might be right for
Multiple Sclerosis
University of Southern California 51
Large-scale testing (Phase 3)Ended earlyNCT03283397
What this trial is testing

A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bosnalijek D.D 301
Not applicableNot Yet RecruitingNCT07292480
What this trial is testing

Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Centre Hospitalier Universitaire de Nīmes 84
Large-scale testing (Phase 3)Study completedNCT01838668
What this trial is testing

An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple SclerosisMultiple Sclerosis
Biogen 225
Not applicableWithdrawnNCT05172466
What this trial is testing

Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Icahn School of Medicine at Mount Sinai
Load More Results